These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2030367)

  • 41. Ocular myasthenia gravis patients following the administration of tacrolimus and steroids.
    Omata T; Fukui K; Kodama K; Watanabe Y; Aoyama H; Fujii K; Shimojo N
    J Neurol Sci; 2019 Jan; 396():30-32. PubMed ID: 30399462
    [No Abstract]   [Full Text] [Related]  

  • 42. Beneficial effects of corticosteroids on ocular myasthenia gravis.
    Kupersmith MJ; Moster M; Bhuiyan S; Warren F; Weinberg H
    Arch Neurol; 1996 Aug; 53(8):802-4. PubMed ID: 8759987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience.
    Prakash KM; Ratnagopal P; Puvanendran K; Lo YL
    J Clin Neurosci; 2007 Mar; 14(3):278-81. PubMed ID: 16597503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experience in the treatment of acute fulminating myasthenia gravis].
    Ouchi M; Shoji Y; Yoshida I; Itoh Y; Ohmi M; Saji K
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb; 40(2):265-72. PubMed ID: 1593167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Tokuda T; Ikeda S
    J Clin Neurosci; 2006 Jan; 13(1):39-44. PubMed ID: 16307880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan.
    Imai T; Utsugisawa K; Murai H; Tsuda E; Nagane Y; Suzuki Y; Minami N; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Akaishi T; Aoki M
    J Neurol Neurosurg Psychiatry; 2018 May; 89(5):513-517. PubMed ID: 29175893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration.
    Tanaka S; Masuda M; Nakajima K; Ido N; Ohtsuka T; Nishida M; Utsumi H; Hirano T
    Int Immunopharmacol; 2009 Mar; 9(3):284-90. PubMed ID: 19101657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of steroid treatment in myasthenia gravis: a retrospective study.
    Cosi V; Citterio A; Lombardi M; Piccolo G; Romani A; Erbetta A
    Acta Neurol Scand; 1991 Jul; 84(1):33-9. PubMed ID: 1927259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EFNS/ENS Guidelines for the treatment of ocular myasthenia.
    Kerty E; Elsais A; Argov Z; Evoli A; Gilhus NE
    Eur J Neurol; 2014 May; 21(5):687-93. PubMed ID: 24471489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of a small thymoma associated with myasthenia gravis in which the tumor was reduced by corticosteroid therapy].
    Mizuno T; Hashimoto T; Yamakawa Y; Niwa H; Masaoka A
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Jun; 40(6):975-7. PubMed ID: 1634847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The continuous treatment of generalized myasthenia gravis with small doses of prednisolone with or wihtout immunosuppressants (author's transl)].
    Ichikawa Y; Nakata Y; Koriyama K; Komatsuda M; Arimori S
    Nihon Naika Gakkai Zasshi; 1976 Jul; 65(7):669-80. PubMed ID: 988093
    [No Abstract]   [Full Text] [Related]  

  • 52. Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis.
    Yoshikawa H; Kiuchi T; Saida T; Takamori M
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):970-7. PubMed ID: 21784757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Steroid treatment for experimental autoimmune myasthenia gravis.
    Barone DA; Lambert DH; Poser CM
    Arch Neurol; 1980 Oct; 37(10):663-6. PubMed ID: 7425891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical manifestations of myasthenia gravis - review of cases seen at the Lagos University Teaching Hospital.
    Ojini FI; Danesi MA; Ogun SA
    Niger Postgrad Med J; 2004 Sep; 11(3):193-7. PubMed ID: 15505649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pneumatosis intestinalis in a patient of myasthenia gravis treated with high-dose corticosteroid].
    Kameyama K; Noguchi Y; Matsumoto T; Takenawa H; Fujigasaki H; Kanda T; Mizusawa H
    Rinsho Shinkeigaku; 2003 May; 43(5):277-80. PubMed ID: 12931635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.
    Minami N; Fujiki N; Doi S; Shima K; Niino M; Kikuchi S; Sasaki H
    J Neurol Sci; 2011 Jan; 300(1-2):59-62. PubMed ID: 21035148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subclinical cardiac involvement in thymomatous Myasthenia Gravis.
    Giallafos E; Zouvelou V; Maurogeni S; Stamboulis E
    Hellenic J Cardiol; 2016; 57(5):345-347. PubMed ID: 28185979
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of alternate-day prednisone therapy on respiratory function in myasthenia gravis.
    Newball HH; Brahim SA
    Thorax; 1976 Aug; 31(4):410-3. PubMed ID: 968798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy.
    Sarnat HB; McGarry JD; Lewis JE
    Neurology; 1977 Jun; 27(6):550-3. PubMed ID: 559263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cell electrophoretic studies of lymphocytes. 3. Effects of administration of a massive dosage of prednisolone on lymphocyte functions in myasthenia gravis].
    Noguchi S
    Rinsho Shinkeigaku; 1976 May; 16(5):373-80. PubMed ID: 986275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.